Status:
COMPLETED
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Retinal Disease
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
In this study we intend to evaluate the outcome of intravitreal avastin on improving the visual acuity and macular edema and late complications of BRVO like NVD and NVE
Detailed Description
After diabetic retinopathy, vein occlusion is the second most common retinovascular disease. According to BVO study the only effective management of it is macular photocoagulation for macular thickeni...
Eligibility Criteria
Inclusion
- patients with acute BRVO with less than three month duration
Exclusion
- vision less than 20/320 and vison more than 20/50
- duration more than 3 months
- history of glaucoma and diabetic retinopathy
- any media opacity that prevent funduscopy
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT00370851
Start Date
August 1 2006
End Date
June 1 2008
Last Update
November 25 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Siamak Moradian, MD
Tehran, Tehran Province, Iran, 16666